- Home
- LEGT vs VOR Comparison
LEGT vs VOR Comparison
Compare LEGT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- VOR
- Stock Information
- Founded
- LEGT 2023
- VOR 2015
- Country
- LEGT United States
- VOR United States
- Employees
- LEGT N/A
- VOR N/A
- Industry
- LEGT
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- LEGT
- VOR Health Care
- Exchange
- LEGT Nasdaq
- VOR Nasdaq
- Market Cap
- LEGT 276.8M
- VOR 261.0M
- IPO Year
- LEGT 2024
- VOR 2021
- Fundamental
- Price
- LEGT $10.77
- VOR $1.60
- Analyst Decision
- LEGT
- VOR Buy
- Analyst Count
- LEGT 0
- VOR 6
- Target Price
- LEGT N/A
- VOR $3.90
- AVG Volume (30 Days)
- LEGT 21.9K
- VOR 4.3M
- Earning Date
- LEGT 01-01-0001
- VOR 11-06-2025
- Dividend Yield
- LEGT N/A
- VOR N/A
- EPS Growth
- LEGT N/A
- VOR N/A
- EPS
- LEGT 0.35
- VOR N/A
- Revenue
- LEGT N/A
- VOR N/A
- Revenue This Year
- LEGT N/A
- VOR N/A
- Revenue Next Year
- LEGT N/A
- VOR N/A
- P/E Ratio
- LEGT $30.68
- VOR N/A
- Revenue Growth
- LEGT N/A
- VOR N/A
- 52 Week Low
- LEGT $10.18
- VOR $0.13
- 52 Week High
- LEGT $10.86
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- LEGT 61.22
- VOR 34.25
- Support Level
- LEGT $10.72
- VOR $1.80
- Resistance Level
- LEGT $10.74
- VOR $2.03
- Average True Range (ATR)
- LEGT 0.01
- VOR 0.13
- MACD
- LEGT 0.00
- VOR -0.05
- Stochastic Oscillator
- LEGT 83.33
- VOR 5.69
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.